Cantitate/Preț
Produs

Intraperitoneal Therapy for Ovarian Cancer

Editat de David Alberts, Mary C. Clouser, Lisa M. Hess
en Limba Engleză Paperback – 13 dec 2014
Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Chemotherapy have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 100329 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 13 dec 2014 100329 lei  6-8 săpt.
Hardback (1) 70090 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 14 sep 2010 70090 lei  6-8 săpt.

Preț: 100329 lei

Preț vechi: 105609 lei
-5% Nou

Puncte Express: 1505

Preț estimativ în valută:
19203 19960$ 15907£

Carte tipărită la comandă

Livrare economică 04-18 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642423574
ISBN-10: 3642423574
Pagini: 164
Ilustrații: VIII, 153 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.24 kg
Ediția:2010
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Cuprins

Current Chemotherapy of Ovarian Cancer.- Principles of Intraperitoneal Chemotherapy.- Intraperitoneal Chemotherapy: Phase III Trials.- Criteria for Using Intraperitoneal (IP) Chemotherapy for Advanced Ovarian Cancer.- Selection and Placement of Intraperitoneal Catheters for IP Chemotherapy for Ovarian Cancer.- Selection of Drugs for Intraperitoneal Chemotherapy for Ovarian Cancer.- Administration Guidelines for Intraperitoneal Chemotherapy for Ovarian Cancer.- Novel Drugs for Intraperitoneal Therapy for Ovarian Cancer.- Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: An Ongoing Research Effort.- Health-Related Quality of Life and Patient-Reported Outcomes.

Notă biografică

Prof. Alberts is Director of the Arizona Cancer Center in Tucson, AZ.He led a workshop on intraperitoneal chemotherapy in January 2006 at the Gynecologic Oncology Group meeting with 400 oncologists and nurses present. He also published the results of the first ever phase III trial comparing IV to IP chemotherapy in the New England Journal of Medicine.

Textul de pe ultima copertă

Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.

Caracteristici

A comprehensive review of intraperitoneal chemotherapy - Explains treatment principles and selection criteria for patients, drugs, and catheters - Presents administration guidelines, discusses novel drugs, and examines the most recent results of clinical trials - Written by highly experienced clinicians Includes supplementary material: sn.pub/extras